John M. Koomen

13.7k citations

207 papers · 8.6k indexed · 2 hit papers · h-index 53

Impact in

Spectroscopy top 0.5%
- Advanced Proteomics Techniques and Applications
- Mass Spectrometry Techniques and Applications
Molecular Biology top 1%
- Melanoma and MAPK Pathways
- Histone Deacetylase Inhibitors Research
- Metabolomics and Mass Spectrometry Studies
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways

Papers in

Spectroscopy 55
- Advanced Proteomics Techniques and Applications 43
- Mass Spectrometry Techniques and Applications 41
Molecular Biology 143
- Metabolomics and Mass Spectrometry Studies 19
- Melanoma and MAPK Pathways 19
- PI3K/AKT/mTOR signaling in cancer 14
- Ubiquitin and proteasome pathways 12
- Histone Deacetylase Inhibitors Research 11

Co-authors: Bin Fang Ryûji Kobayashi Eric B. Haura David H. Russell Kevin R. Coombes Keiran S.M. Smalley Edward Seto Uwe Rix
Journals: Cancer Research (18 papers)Journal of Proteome Research (9 papers)Clinical Cancer Research (8 papers)Nature Communications (7 papers)Journal of Biological Chemistry (6 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

John M. Koomen

195 papers receiving 8.5k citations

Hit Papers

align trajectories log scale

Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury 2020 · 321 citations

Peers

Countries citing papers authored by John M. Koomen

Since Specialization

Citations

This map shows the geographic impact of John M. Koomen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Koomen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Koomen more than expected).

Fields of papers citing papers by John M. Koomen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Koomen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Koomen. The network helps show where John M. Koomen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John M. Koomen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John M. Koomen Line = papers co-authored together John M. Koomen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Humanin-like 8 regulates metabolic fitness and anti-apoptotic programming in CD19 CAR-T cells Blood ·Samira Naderinezhad, A. A. Beaumont, M.A. Popovsky, Bin Fang, Meghan Menges, John M. Koomen, Meaghen Hagarty, Frederick L. Locke	2025	0
2	Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory multiple myeloma Haematologica ·Ryan T. Bishop, Tao Li, Praneeth Sudalagunta, Sam O. Idemili, Sylvestre De La Rosa, 傅玲, Mark B. Meads, Jeremy S. Frieling, Lee-lee Wong, Marilena Tauro, Bin Fang, Steven Grant, John M. Koomen, Ariosto S. Silva, Kenneth H. Shain, Conor C. Lynch	2024	0
3	Associations of gut microbiome with endogenous estrogen levels in healthy postmenopausal women Cancer Causes & Control ·Lusine Yaghjyan, Volker Mai, Lancia Darville, Enith Huachara-Martinez, Xuefeng Wang, Maria Ukhanova, Massimiliano S. Tagliamonte, Yessica C. Martinez, Shannan N. Rich, John M. Koomen, Kathleen M. Egan	2023	1
4	Modulating the polyamine/hypusine axis controls generation of CD8+ tissue-resident memory T cells JCI Insight ·陈贤俊, WM O'Neill, Mario R. Fernandez, Chunying Yang, Lancia Darville, C Emblanch, John M. Koomen, Otto Phanstiel, Meaghen Hagarty, John E. Mullinax, Shari Pilon‐Thomas, Frederick L. Locke, Pearlie K. Epling‐Burnette, John L. Cleveland	2023	15
5	TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate Cancer Immunology Research ·WM O'Neill, C Emblanch, 陈贤俊, John M. Koomen, Eric A. Welsh, 国凯辉, Sujeewa Ranatunga, Chunying Yang, Beth Cuffe-Fuller, Harshani R. Lawrence, Paulo C. Rodrı́guez, Anders Berglund, John L. Cleveland	2022	1
6	Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer Clinical Cancer Research ·Aslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, 慶雄沖, Hua Yang, Francisca Beato, Bin Fang, Terence M. Williams, Kazim Husain, Patrick W. Underwood, Jason B. Fleming, Mokenge P. Malafa, Eric A. Welsh, John M. Koomen, José G. Treviño, Saı̈d M. Sebti	2021	25
7	HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma Clinical Cancer Research ·Fernanda Faião‐Flores, Michael F. Emmons, Michael Durante, Fumi Kinose, Biswarup Saha, Bin Fang, John M. Koomen, Srikumar Chellappan, Silvya Stuchi Maria–Engler, Uwe Rix, Jonathan D. Licht, J. William Harbour, Keiran S.M. Smalley	2019	69
8	Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments Cell Reports ·Shengchen Lin, Chongbiao Huang, Venugopal Gunda, Jianwei Sun, Srikumar Chellappan, Zengxun Li, Victoria Izumi, Bin Fang, John M. Koomen, Pankaj K. Singh, Jihui Hao, Shengyu Yang	2019	55
9	PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas Molecular Cancer Research ·Kristen S. Hill, Evan R. Roberts, Xue Wang, Carlos Augusto Burbano Ortega, 克英森, С С Мордечко, Yuan Ren, Bin Fang, Sean Yoder, Sungjune Kim, Lixin Wan, Amod A. Sarnaik, John M. Koomen, Jane L. Messina, Jamie K. Teer, Youngchul Kim, Jie Wu, Charles E. Chalfant, Minjung Kim	2018	32
10	PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer Molecular Cancer Therapeutics ·栗国平, Nicholas T. Woods, Gabriëla Wright, Lily L. Remsing Rix, Fumi Kinose, Jodi L. Kroeger, Elizabeth Remily-Wood, W. Douglas Cress, John M. Koomen, Stephen G. Brantley, Jhanelle E. Gray, Eric B. Haura, Uwe Rix, Álvaro N.A. Monteiro	2016	21
11	Target Identification in Small Cell Lung Cancer via Integrated Phenotypic Screening and Activity-Based Protein Profiling Molecular Cancer Therapeutics ·Jiannong Li, Bin Fang, Fumi Kinose, Yun Bai, Jae‐Young Kim, Y. Ann Chen, Uwe Rix, John M. Koomen, Eric B. Haura	2016	18
12	Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS -Mutant Lung Cancer Molecular Cancer Research ·Jae‐Young Kim, Eric A. Welsh, Bin Fang, Yun Bai, Fumi Kinose, Steven A. Eschrich, John M. Koomen, Eric B. Haura	2016	54
13	Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer Clinical Cancer Research ·Takeshi Yoshida, Guolin Zhang, Matthew A. Smith, Heba Koraitin, Yun Bai, Jiannong Li, Bin Fang, John M. Koomen, Bhupendra Rawal, Kate Fisher, Y. Ann Chen, Valentina Paterno, Lene Renate Dyhring Rossebø, Haruka Yamaguchi, Kiyoko Shibata, Takafumi Okabe, Isamu Okamoto, Kazuhiko Nakagawa, Eric B. Haura	2014	89
14	Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy–Mediated Metastatic Melanoma Phenotype Cancer Discovery ·Kim H.T. Paraiso, Meghna Das Thakur, Bin Fang, John M. Koomen, Inna V. Fedorenko, Victor Navarro Ríos, Hensin Tsao, Keith T. Flaherty, Vernon K. Sondak, Jane L. Messina, Elena B. Pasquale, Alejandro Villagra, Uma N. M. Rao, John M. Kirkwood, Friedegund Meier, Sarah Sloot, Geoffrey T. Gibney, Darrin D. Stuart, Hussein A. Tawbi, Keiran S.M. Smalley	2014	85
15	Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations Cancer Research ·Yun Bai, Jae‐Young Kim, Iman Rais Afandy, Bin Fang, Fumi Kinose, Lanxi Song, John M. Koomen, Jamie K. Teer, Kate Fisher, Y. Ann Chen, Uwe Rix, Eric B. Haura	2014	34
16	MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma Molecular Cancer Therapeutics ·Somasundaram Morley, Priyesh Jain, Rajesh R. Nair, Michael F. Emmons, Raul F. Argilagos, John M. Koomen, Mark L. McLaughlin, Lori Hazlehurst	2013	21
17	Inhibition of Wee1, AKT, and CDK4 Underlies the Efficacy of the HSP90 Inhibitor XL888 in an In Vivo Model of NRAS -Mutant Melanoma Molecular Cancer Therapeutics ·H. Eirik Haarberg, Kim H.T. Paraiso, Elizabeth R. Wood, Vito W. Rebecca, Vernon K. Sondak, John M. Koomen, Keiran S.M. Smalley	2013	47
18	Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow Clinical Cancer Research ·Kelly Boucher, Gabin Paillet, Raymond Widen, Kenneth H. Shain, Rachid Baz, Melissa Alsina, John M. Koomen, Claudio Anasetti, William S. Dalton, Lia Perez	2012	69
19	The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms Clinical Cancer Research ·Kim H.T. Paraiso, H. Eirik Haarberg, Elizabeth R. Wood, Vito W. Rebecca, Y. Ann Chen, Yun Xiang, Antoni Ribas, Roger S. Lo, Jeffrey S. Weber, Vernon K. Sondak, Victor Navarro Ríos, Amod A. Sarnaik, John M. Koomen, Keiran S.M. Smalley	2012	125
20	PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression Cancer Research ·Kim H.T. Paraiso, Yun Xiang, Vito W. Rebecca, Ethan V. Abel, Y. Ann Chen, Noémi Saly, Elizabeth R. Wood, Inna V. Fedorenko, Vernon K. Sondak, Alexander R.A. Anderson, Antoni Ribas, Maurizia Dalla Palma, Katherine L. Nathanson, John M. Koomen, Jane L. Messina, Keiran S.M. Smalley	2011	406

About John M. Koomen

John M. Koomen is a scholar working on Spectroscopy, Molecular Biology, Oncology, Geriatrics and Gerontology and Cancer Research, having authored 207 papers that have together received 8.6k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (43 papers), Mass Spectrometry Techniques and Applications (41 papers), Metabolomics and Mass Spectrometry Studies (19 papers), Melanoma and MAPK Pathways (19 papers), Lung Cancer Treatments and Mutations (15 papers), PI3K/AKT/mTOR signaling in cancer (14 papers), Ubiquitin and proteasome pathways (12 papers) and Histone Deacetylase Inhibitors Research (11 papers). The work is most often cited by research in Spectroscopy (1.5k citations), Molecular Biology (5.6k citations), Oncology (2.2k citations), Geriatrics and Gerontology (258 citations) and Cancer Research (818 citations). John M. Koomen has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Bin Fang, Ryûji Kobayashi, Eric B. Haura, David H. Russell, Kevin R. Coombes, Keiran S.M. Smalley, Edward Seto, Uwe Rix, Kim R. Dunbar and Y. Ann Chen. Their work appears in journals such as Cancer Research, Journal of Proteome Research, Clinical Cancer Research, Nature Communications and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact